Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/20/2000CN1056616C Membrane protein polypeptide having supporting pre-B cell growth and gene thereof
09/19/2000US6121521 Formed by joining the 5' portion of a synthetic maize optimized cry1b gene to the 3' end of a full-length synthetic maize optimized cry1a gene to generate a full-length hybrid cry1b gene
09/19/2000US6121513 Sulfonamide resistance in plants
09/19/2000US6121512 Cytochrome P-450 constructs and method of producing herbicide-resistant transgenic plants
09/19/2000US6121511 Production of transgenic impatiens
09/19/2000US6121436 Nucleic acid sequence coding alfalfa fungicide protein; for prevention of parasite infection; fungicides
09/19/2000US6121435 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/19/2000US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins
09/19/2000US6121433 For diagnostic, research and therapeutic use; mimic or modulate proteins, enzymes, nucleic acids and lipids
09/19/2000US6121428 Protein recovery
09/19/2000US6121427 Major outer membrane protein CD of branhamella
09/19/2000US6121426 Fibrin binding domain polypeptides and uses and methods of producing same
09/19/2000US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders
09/19/2000US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage
09/19/2000US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides
09/19/2000US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
09/19/2000US6121047 Antisense modulation of SHP-1 expression
09/19/2000US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache
09/19/2000US6121044 Potent antigen presenting cell composition
09/19/2000US6121043 Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome
09/19/2000US6121041 Use of microorganisms for decellularizing bioprosthetic tissue
09/19/2000US6121035 Amino acid sequences; for screening drugs and producing antibodies
09/19/2000US6121034 Nucleic acid which encodes defined amino acid sequence; for recombinant production of enzyme; improved nutrient quality in feeds
09/19/2000US6121030 CSAPK-2 protein and uses therefor
09/19/2000US6121028 MurE
09/19/2000US6121021 Modified human immunodeficiency virus genome devoid of long terminal repeats, with vpr and tat sequences disabled, and linked to constitutive promoter; for stable, long-term production of nonreplicating immunogens for vaccines
09/19/2000US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents
09/19/2000US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases
09/19/2000US6121017 Nucleotide and amino acid sequences; for diagnostic evaluation and prognosis of various disorders
09/19/2000US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof
09/19/2000US6121015 Drug screening by transfecting cells with nucleic acid, expressing receptor, selecting compounds binding to receptor, comparing binding to other receptors, choosing compounds which have lower affinity to other receptors
09/19/2000US6121014 Method for producing a plant-optimized nucleic acid coding sequence
09/19/2000US6121007 Reaction-based selection for expression of and concentration of catalytic moieties
09/19/2000US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/19/2000US6121003 Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use
09/19/2000US6121000 Nucleotide sequences; antimetastatis agents; for inhibiting growth of chemotherapy resistant tumors and increasing sensitivity of tumors to chemotherapy
09/19/2000US6120999 Histidine kinase two-component in Candida albicans
09/19/2000US6120998 Endo-xyloglucan transferase
09/19/2000US6120996 Accurate and reproducible proecess by cleaving cdna corresponding to messenger rna with restriction endonuclease, amplifying with one or more primers, separating fragments and assessing amounts of fragments
09/19/2000US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same
09/19/2000US6120989 Isolated human cytomegalovirus polypeptides and uses thereof
09/19/2000US6120985 Pressure-enhanced extraction and purification
09/19/2000US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases
09/19/2000US6120798 Liposome-entrapped polynucleotide composition and method
09/19/2000US6120776 Kit containing vaccine and diagnostic test
09/19/2000US6120774 Heterophil-adapted poultry vaccine
09/19/2000US6120773 Recombinant herpes simplex viruses vaccines and methods
09/19/2000US6120771 Isolated polypeptide; diagnosis, therapy
09/19/2000US6120769 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
09/19/2000US6120767 Genetic engineering
09/19/2000US6120765 Purified peptide
09/19/2000US6120764 Genetic engineering
09/19/2000US6120763 Compositions and methods for enhanced tumor cell immunity in vivo
09/19/2000US6120760 Isolated protein; hybrid; bone disorders
09/19/2000US6120641 Process architecture and manufacturing tool sets employing hard mask patterning for use in the manufacture of one or more metallization levels on a workpiece
09/19/2000CA2301407A1 Production of l-amino acids by fermentation using coryneform bacteria
09/19/2000CA2300475A1 Cre-inducible expression system
09/19/2000CA2266295A1 Method of modifying plant metabolism and development
09/19/2000CA2065365C Bovine coronavirus polypeptides and vaccines
09/19/2000CA2053242C Protease inhibitor
09/19/2000CA2050601C Production in bacteria and yeast of hemoglobin and analogues thereof
09/17/2000CA2300782A1 Modified factor viii cdna
09/15/2000CA2300639A1 Methods and apparatus for analyzing gene expression data
09/15/2000CA2265241A1 Heteroduplex pcr cloning
09/14/2000WO2000054057A1 Selection of intracellular immunoglobulins
09/14/2000WO2000053813A1 Pangenomic libraries
09/14/2000WO2000053812A2 Replica amplification of nucleic acid arrays
09/14/2000WO2000053807A1 Solid medium and process for the storage and rapid purification of nucleic acid
09/14/2000WO2000053806A1 Method of identifying gene transcription patterns
09/14/2000WO2000053801A1 Intact cell assay for protein tyrosine phosphatases
09/14/2000WO2000053795A1 Adipose-derived stem cells and lattices
09/14/2000WO2000053794A2 Trait-associated gene identification method
09/14/2000WO2000053790A1 Target cell-specific, multivalent proteins (mvp)
09/14/2000WO2000053789A2 Retroviral expression vectors on the basis of herv- long terminal repeat sequences
09/14/2000WO2000053788A2 Compositions and methods for recombinant adeno-associated virus production
09/14/2000WO2000053787A1 Prrsv vaccines
09/14/2000WO2000053786A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000WO2000053785A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins
09/14/2000WO2000053784A1 Methods of using viral replicase
09/14/2000WO2000053783A1 Agrobacterium-mediated transformation of cotton with novel explants
09/14/2000WO2000053782A2 Herbicide target genes and methods
09/14/2000WO2000053781A1 Generation of conditional yeast mutants, methods and reagents related thereto
09/14/2000WO2000053780A2 Multiple component rna vector system for expression of foreign sequences
09/14/2000WO2000053779A1 Translation regulation system and methods for use thereof
09/14/2000WO2000053778A1 Promoters
09/14/2000WO2000053777A1 Preparation of peptides by use of human glucagon sequence as a fusion expression partner
09/14/2000WO2000053776A2 Human kallikrein-like genes
09/14/2000WO2000053775A2 Prevention and treatment of viral infections
09/14/2000WO2000053774A2 Metalloproteinases and methods of use therefor
09/14/2000WO2000053773A2 Methods for mitochondrial gene therapy
09/14/2000WO2000053772A1 Dna polymerase from pyrobaculum islandicum
09/14/2000WO2000053771A1 Genetic manipulation of isoflavonoids
09/14/2000WO2000053770A1 cDNA MOLECULES OF THE MEMBERS OF GENE FAMILY ENCODING HUMAN FATTY ACID DESATURASES AND THEIR USE IN DIAGNOSIS AND THERAPY
09/14/2000WO2000053768A1 Method for improving the agronomic and nutritional value of plants
09/14/2000WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines
09/14/2000WO2000053766A1 Non-spreading pestivirus
09/14/2000WO2000053765A1 Cloning and expression of haemophilus somnus transferrin-binding proteins
09/14/2000WO2000053764A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/14/2000WO2000053763A1 Maize metallothionein gene and promoter
09/14/2000WO2000053762A2 Plant disease resistance associated genes and uses thereof